Letter: Colitic cancer developed after introduction of azathioprine [2]

Digestive Diseases and Sciences

Volumn 49, Issue 10, 2004, Pages 1727-1729

  Sasaki, Jun Ichi ^a   Kawamura, Yutaka J ^a   Konishi, Fumio ^a   Tosha, Tsutomu ^a  

^a Omiya Medical School   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; ANAMNESIS; BONE METASTASIS; CANCER CELL; CANCER INVASION; CASE REPORT; CLINICAL FEATURE; COLON CANCER; COLON RESECTION; COLONOSCOPY; COLOSTOMY; DEATH; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FAMILY HISTORY; HISTOPATHOLOGY; HOSPITAL; HUMAN; INTESTINE BIOPSY; LAPAROTOMY; LETTER; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECTUM DISEASE; RELAPSE; SCREENING TEST; SIGMOID; ULCERATIVE COLITIS; ADENOCARCINOMA; CHEMICALLY INDUCED DISORDER; COLON DISEASE; COLON TUMOR; FATALITY; INTESTINE PERFORATION; PATHOLOGY;

ADENOCARCINOMA; ADULT; AZATHIOPRINE; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; COLONOSCOPY; FATAL OUTCOME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL PERFORATION; MALE; SIGMOID DISEASES;

EID: 5044232578     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000043393.67919.fe     Document Type: Letter

References (18)

1. Eaden JA, Abrams KR, Mayberry JF: The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 48:526-535, 2001
2. Hogezand RA, Eichhorn A, Choudry A, Veenendaal A, Lamers CB: Malignancies in inflammatory bowel disease: fact or fiction? Scand J Gastroenterol Suppl 236:48-53, 2002
3. Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A: Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 42:711-714, 1998
4. Palli D, Trallori G, Saieva C, Tarantino O, Edili E, D'Albasio G, Pacini F, Masala G: General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: The Florence Study. Gut 42:175-179, 1998
5. Mayer R, Wong WD, Rothenberger DA, Goldberg SM, Madoff RD: Colorectal cancer in inflammatory bowel disease: A continuing problem. Dis Colon Rectum 42:343-347, 1999
6. Solomon MJ, Schnitzler M: Cancer and inflammatory bowel disease: Bias, epidemiology, surveillance, and treatment. World J Surg 22:352-358, 1998
7. Karlen P, Lofberg R, Brostrom O, Leijonmarck CE, Hellers G, Persson PG: Increased risk of cancer in ulcerative colitis: A population-based cohort study. Am J Gastroenterol 94:1047-1052, 1999
8. Delco F, Sonnenberg A: The unsolved problem of surveillance for colorectal cancer in ulcerative colitis. Can J Gastroenterol 13:655-660, 1999
9. Fracasso P, Assisi D, Stigliano V, Casale V: Colorectal cancer complicating ulcerative colitis: An institutional series. J Exp Clin Cancer Res 18:29-32, 1999
10. Geboes K: Ulcerative colitis and malignancy. Acta Gastroenterol Belg 63:279-283, 2000
11. Tan CW, Wilson GE, Howat JM, Shereeve DR: Rectal lymphoma in ulcerative colitis treated with azathioprine. Eur J Gastroenterol Hepatol 13:989-992, 2001
12. Aithal GP, Mansfield JC: Review article: The risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment. Aliment Pharmacol Ther 15:1101-1108, 2001
13. Garlicki M, Wierzbicki K, Przybylowski P, Drop D, Biernat M, Rudzinski P, Olszewska B, Dziatkowiak A: The incidence of malignancy in heart transplant recipients. Ann Transplant 3:41-47, 1998
14. Gunji Y, Sakamoto K, Kamura K, Yamada K, Kashiwabara H, Shimada H, Hori S, Suzuki T, Ochiai T: Long-term outcomes of immunosuppressed renal transplant recipients with malignancies. Surg Today 31:492-496, 2001
15. Yoshimura T, Tamai Y, Takami H, Kariya K, Nakahata R, Tsushima K, Munakata A, Kawamura S: Rapidly progressive irradiated cervical cancer that metastasized to the liver during therapy for idiopathic thrombocytopenic purpura. Rinsho Ketsueki 40:150-152, 1999
16. Fletcher L, Maddocks JL: Assay of thioinosinic acid, an active metabolite of azathioprine, in human lymphocytes. Br J Clin Pharmacol 10:287-292, 1980
17. Nielsen OH, Vainer B, Rask-Madsen J: Review article: The treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine. Aliment Pharmacol Ther 15:1699-1708, 2001
18. Connell WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, Lennard-Jones JE: Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 343:1249-1252, 1994